Swiss Pharmaceuticals YK-11 – Steroidal SARM
Swiss Pharmaceuticals YK-11 contains a synthetic steroidal compound commonly classified as a selective androgen receptor modulator (SARM).
YK-11 has attracted scientific interest because of its interaction with androgen receptors and its potential influence on follistatin expression, a protein involved in the regulation of muscle development.
What is YK-11?
YK-11 differs structurally from many non-steroidal SARMs because it possesses a steroidal molecular structure.
Preclinical laboratory research has investigated its effects on androgen receptor activity and muscle-cell differentiation. Some cellular studies have reported increased follistatin expression, which is associated with the regulation of myostatin signaling.
However, these findings have not established that YK-11 increases muscle mass, strength or athletic performance in humans.
Compound Characteristics
-
Steroidal selective androgen receptor modulator
-
Investigated for androgen receptor activity
-
Studied in relation to follistatin expression
-
Experimental compound with limited scientific evidence
-
No established clinical efficacy or safe human dosage
Product Information
| Specification |
Details |
| Brand |
Swiss Pharmaceuticals |
| Product |
YK-11 |
| Active ingredient |
YK-11 |
| Amount per capsule |
4 mg |
| Container |
60 capsules |
| Declared servings |
60 |
Safety and Regulatory Information
YK-11 is an experimental compound and has not been approved as a medicine or dietary supplement for human use.
Its potential effects on liver function, cardiovascular health, hormonal regulation and other physiological systems have not been adequately evaluated in controlled human clinical trials.
YK-11 is also prohibited in competitive sport under anti-doping regulations.
Warning: Human consumption is not recommended. No scientifically established safe dosage or treatment duration is available. Product classification and legal marketability must be verified in the country of sale.